Log in
Home
Log in

Jobs

584 days ago

Postdoctoral

Ontario Institute for Cancer Research -

Position: Postdoctoral Fellow
Site: MaRS Centre, Toronto
Department: Diagnostic Development
Reports To: Principal Research Scientist
Salary:  Commensurate with level of experience
Hours: 35 hours/week
Status: Full-time, Temporary (2 year contract)

The Ontario Institute for Cancer Research (OICR) is seeking a highly motivated and qualified postdoctoral fellow who possesses relevant training in proteomics or molecular biology and interested in cancer biology to join the Diagnostic Development program. This is a 2-year contract with the potential to extend.

The successful candidate will join a highly dynamic and translational research program in biomarker discovery in various cancer types. The program aims to develop personalized medicine approaches that maximize the chance of positive outcomes for those diagnosed with cancer. The project will use clinical cohorts to examine the predictive and translational value of the tumour and the immune microenvironment on treatment. The aim of the project is to develop and perform spatial transcriptomic and proteomic profiling to identify and characterise targets and associated biomarkers for cancer treatment.

The MaRS Centre has a mandatory COVID-19 vaccination policy in place that requires proof of full COVID-19 vaccination or proof of a medical exemption issued pursuant to the Government of Ontario guidelines.  Accordingly, as a condition of employment, new employees who are required to work on-site are required to be fully vaccinated for COVID-19 subject to the duty to accommodate on the basis of protected grounds pursuant to the Ontario Human Rights Code.

Fully vaccinated is defined as having received all of the required doses of a Health Canada approved vaccine and having received the final dose at least 14 days before your employment start date.

As described above, the requirement to be fully vaccinated is subject to the Ontario Human Rights Code. If the candidate is unable to receive the COVID-19 vaccine for a reason protected by the Code, requests for accommodation from the vaccine policy will be assessed on a case-by-case basis.

Learn more about working at OICR here

584 days ago

Postdoctoral

Ontario Institute for Cancer Research -

Position: Postdoctoral Fellow in Computational Genomics
Site: MaRS Centre, Toronto
Department: Computational Biology
Reports To: Shraddha Pai
Salary: Commensurate with level of experience
Hours: 35 hours/week
Status: Full-time, Temporary (1-year contract)

The Ontario Institute for Cancer Research (OICR) is seeking a dynamic, collaborative postdoctoral fellow to join a team developing computational algorithms for cancer drug target prioritization using genomics, biological networks, and systems medicine-based approaches.

The goal of the project is to create an algorithm to prioritize lead molecules for drug targeting by integrating prior ‘omic and non-‘omic knowledge to maximize functional relevance and minimize off-target effects. The algorithm will use network-based approaches, and will incorporate genomic prior knowledge such as tissue-specific transcriptomic and proteomic profiles, known oncogenic mutations, and target druggability, as well as non-‘omic sources such as reports of adverse drug reactions. The successful candidate will lead method development, benchmarking for method optimization, and manuscript writing of results. Prioritized molecules will be experimentally verified by members of the team from OICR’s Drug Discovery group.

The Pai Lab at the Ontario Institute for Cancer Research develops computational methods for precision medicine, with a focus on network and systems medicine. The project is a collaboration between the Ontario Institute for Cancer Research’s Adaptive Oncology and Drug Discovery teams, which includes the labs of Rima Al-Awar, Richard Marcellus, Lincoln Stein and Shraddha Pai. While this posting is for a one year initial contract, a contract extension for a second year is a strong possibility.

The successful candidate will gain the experience of working in an interdisciplinary team of computational biologists and pharmacologists, and be exposed to the process of drug discovery technology development.  The candidate will be part of the rich scientific environment of the OICR, with opportunities for development of technical, leadership, and entrepreneurial skills. The candidate will also have the opportunity to learn about the space for biomedical technology development for commercialization.

The MaRS Centre has a mandatory COVID-19 vaccination policy in place that requires proof of full COVID-19 vaccination or proof of a medical exemption issued pursuant to the Government of Ontario guidelines.  Accordingly, as a condition of employment, new employees who are required to work on-site are required to be fully vaccinated for COVID-19 subject to the duty to accommodate on the basis of protected grounds pursuant to the Ontario Human Rights Code.

Fully vaccinated is defined as having received all of the required doses of a Health Canada approved vaccine and having received the final dose at least 14 days before your employment start date.

As described above, the requirement to be fully vaccinated is subject to the Ontario Human Rights Code. If the candidate is unable to receive the COVID-19 vaccine for a reason protected by the Code, requests for accommodation from the vaccine policy will be assessed on a case-by-case basis.

To learn more about working at OICR, visit our career page.

654 days ago

Postdoctoral

Beth Israel Deaconess Medical Center/Harvard Medical School -

  • Integrating Omics datatypes to build actionable models.
  • Developing miRNA diagnostics using miRNA profiling from concordant peripheral and brain tissue profiles of highly phenotyped subjects using miRNA profiles from serum of phenotype subjects.

Project leverages:

  • Whole genome sequencing of large cohorts of Alzheimer’s subjects.
  • 4000+ subjects
  • Resilience against AD pathology is a focus
  • Modelling resilience to AD pathology against AD in 3D systems (R01 project)
  • Determining single cell signatures of resilience to AD pathology with the CIRCUITS consortium
  • Spatial transcriptomics, single cell nuclear RNAseq, miRNA and whole RNA assays of ‘extreme phenotype’ centenarian subjects who show resistance or resilience to AD
  • Mapping the AD continuum using pathway activity signatures {AD GeneDex}
  • using reference signatures for AD facets and predicting and testing interventions that perturb or enhance AD events

676 days ago

Postdoctoral

Canada's Michael Smith Genome Sciences Centre (GSC) -

Job Reference Number: PDF_01553_Steif Lab_2022_05_16

We are currently looking for a Postdoctoral Fellow to join Dr. Adi Steif’s computational biology group.

The successful incumbent will lead the analysis of single cell data from a novel instrument, under development in collaboration with the groups of Dr. Karen Cheung (Biomedical Engineering) and Dr. Marco Marra (GSC / Medical Genetics). Funded by Genome BC, the project aims to improve the scalability and accuracy of cell isolation, in order to investigate tumour cellular diversity and evolution.

The position is anchored within a team of exceptional scientists, computational biologists and programmers, which collaborate directly on improving genome sequencing technology, interpretation and application. By working within the Steif Lab at the GSC, you will develop close relationships with world-renown specialists in bioinformatics and have access to one of the most robust computational and next generation genome sequencing technology facilities in Canada, all while living in one of the most beautiful, diverse and eclectic cities in the world.

This is an opportunity to work with highly motivated colleagues in a science-oriented, creative and dynamic environment. We offer a competitive salary, excellent benefits and significant career development opportunities.

676 days ago

Postdoctoral

University Health Network -

A combination of engineered features and deep learning models will be used to extract and jointly analyze the imaging and genomic data. The first objective is to develop and evaluate novel computational imaging processing methods applied to multiple cancer types treated with chemotherapies, target therapies or immunotherapies. The second objective is to develop a cloud-based platform to facilitate the visualization and basic analysis of radiomics+genomics data in collaboration with the Software Engineers in the Haibe-Kains Laboratory (bhklab.ca).

This project (OCTANE 2.0) is funded by the Ontario Institute for Cancer Research and supported by Canexia Health. The candidate will be working in the Haibe-Kains Lab at the Princess Margaret Cancer Centre, University Health Network in collaboration with the Cancer Genomics Program and the Quantitative Imaging for Personalized Cancer Medicine, Techna Institute. A description of the project is available here.